Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Ciulla

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Ophthalmology|August 4, 2010
Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trialJeffrey S Heier, David Brown, Thomas Ciulla, et al.
Ophthalmology Science|September 27, 2024
Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation TrialMark R Barakat, David Brown, Allen Hu, et al.
Human Gene Therapy|January 15, 2021
Host Immune Responses after Suprachoroidal Delivery of AAV8 in Nonhuman Primate EyesSook Hyun Chung, Iris Natalie Mollhoff, Alaknanda Mishra, et al.
Clinical & Experimental Ophthalmology|March 8, 2012
Impaired ocular blood flow regulation in patients with open-angle glaucoma and diabetesYochai Shoshani, Alon Harris, Mohammadali M Shoja, et al.
The British Journal of Ophthalmology|February 6, 2021
Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA)Christopher Ryan Henry, Milan Shah, Mark R Barakat, et al.
The British Journal of Ophthalmology|March 13, 2021
Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA)Rahul N Khurana, Pauline Merrill, Steven Yeh, et al.
Ophthalmology|June 7, 2011
Primary endpoint results of a phase II study of vascular endothelial growth factor trap-eye in wet age-related macular degenerationDavid M Brown, Jeffrey S Heier, Thomas Ciulla, et al.
Ophthalmology|March 6, 2010
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insertPeter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, et al.
Ophthalmology|December 11, 2012
Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implantsPeter A Campochiaro, Quan Dong Nguyen, Gulnar Hafiz, et al.
Ophthalmology|April 5, 2011
Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edemaPeter A Campochiaro, David M Brown, Andrew Pearson, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Ophthalmology|August 4, 2010
Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trialJeffrey S Heier, David Brown, Thomas Ciulla, et al.
Ophthalmology Science|September 27, 2024
Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation TrialMark R Barakat, David Brown, Allen Hu, et al.
Human Gene Therapy|January 15, 2021
Host Immune Responses after Suprachoroidal Delivery of AAV8 in Nonhuman Primate EyesSook Hyun Chung, Iris Natalie Mollhoff, Alaknanda Mishra, et al.
Clinical & Experimental Ophthalmology|March 8, 2012
Impaired ocular blood flow regulation in patients with open-angle glaucoma and diabetesYochai Shoshani, Alon Harris, Mohammadali M Shoja, et al.
The British Journal of Ophthalmology|February 6, 2021
Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA)Christopher Ryan Henry, Milan Shah, Mark R Barakat, et al.
The British Journal of Ophthalmology|March 13, 2021
Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA)Rahul N Khurana, Pauline Merrill, Steven Yeh, et al.
Ophthalmology|June 7, 2011
Primary endpoint results of a phase II study of vascular endothelial growth factor trap-eye in wet age-related macular degenerationDavid M Brown, Jeffrey S Heier, Thomas Ciulla, et al.
Ophthalmology|March 6, 2010
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insertPeter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, et al.
Ophthalmology|December 11, 2012
Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implantsPeter A Campochiaro, Quan Dong Nguyen, Gulnar Hafiz, et al.
Ophthalmology|April 5, 2011
Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edemaPeter A Campochiaro, David M Brown, Andrew Pearson, et al.
Pageof 3